Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 19.34
-0.11 (-0.57%)
Apr 22, 2026, 10:05 AM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 3.24 billion as of April 21, 2026. Its market cap has decreased by -20.93% in one year.
Market Cap
3.24B
Enterprise Value
3.10B
Revenue
574.88M
Ranking
n/a
PE Ratio
20.69
Stock Price
19.34
Market Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 3.24B, a decrease of -41.44%. That is a compound annual growth rate of -8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.24B | -16.45% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition